Post‐traumatic growth in survivors of allogeneic hematopoietic stem cell transplantation

Jeon, Mijin; Yoo, Il Young; Kim, Sue; Lee, Jehwan

doi:10.1002/pon.3724

Cited by 23 publications

(24 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Resultsmentioning

confidence: 99%

“…PTG is a positive psychological change experienced as a result of exposure to traumatic or highly challenging events, and is seen in HCT survivors who report emotional growth beyond their pre-transplant levels (90, 91). PTG is associated with enhanced appreciation of life, improved relationships, existential growth, increased self-confidence and self-esteem (90, 92). Factors that predict PTG include female gender, younger age, and higher levels of social support, spirituality, and resilience although the impact of these variables is not consistent across studies (63, 90, 92–94).…”

Section: Resultsmentioning

confidence: 99%

“…PTG is associated with enhanced appreciation of life, improved relationships, existential growth, increased self-confidence and self-esteem (90, 92). Factors that predict PTG include female gender, younger age, and higher levels of social support, spirituality, and resilience although the impact of these variables is not consistent across studies (63, 90, 92–94). Possible mediators of PTG include social support, proactive counseling by the health care team, and cognitive processing of the transplant experience (90).…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report

Bevans

El‐Jawahri

Tierney

et al. 2017

Biology of Blood and Marrow Transplantation

128

145

View full text Add to dashboard Cite

In 2015 the National Institutes of Health (NIH) convened six working groups to address the research needs and best practices for patient-centered late effects of hematopoietic stem cell transplantation (HCT) survivors. The Patient-Centered Outcomes Working Group, charged with summarizing the HRQOL evidence base, used a scoping review approach to efficiently survey the large body of literature in adult and pediatric HCT survivors over 1 year after transplantation. The goals of this paper are to 1) summarize the current literature describing patient-centered outcomes (PCO) in survivors including the various dimensions of healthrelated quality of life affected by HCT and describe interventions tested to improve these outcomes; 2) highlight areas with sufficient evidence allowing for integration into standard practice; 3) address methodological issues that restrict progress in this field; 4) identify major gaps to guide future research; and 5) specify priority research recommendations. PCOs were summarized within physical, psychological, social and environmental domains, as well as for adherence to treatment, and health behaviors. Interventions to improve outcomes were evaluated for evidence of efficacy, although few interventions have been tested in long-term HCT survivors. Methodologic issues defined included lack of consistency in the selection of PCO measures, along with the absence of a standard for timing, frequency, and mode of administration. Recommendations for HCT survivorship care included: integration of annual screening of PCOs; use of evidence based practice guidelines; and provision of treatment summaries and survivorship care plans after HCT. Three priority research recommendations included: 1) Design and test risk-targeted interventions with dose intensity modulation matching the needs of HCT survivors with priority domains including sexual dysfunction, fatigue, sleep disruption, non-adherence to medications & recommended health care, health behaviors including physical inactivity and healthy eating, and psychological dysfunction, with particular consideration of novel technologies to reach HCT survivors distant from their transplant centers, 2) Design a consensus based methodologic framework for outcomes evaluation, and 3) Evaluate and compare existing practices for integrating PCOs screening and interventions across HCT survivorship programs.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report

Bevans

El‐Jawahri

Tierney

et al. 2017

Biology of Blood and Marrow Transplantation

128

145

View full text Add to dashboard Cite

show abstract

“…Therefore, and as suggested by Dirik and Karanci (2008), it would be very advisable to strengthen healthy coping strategies to be able to reinforce posttraumatic growth. It would also be beneficial to increase posttraumatic growth by means of intervention based, among others, on self-help groups or cognitive-behavioral therapy, as demonstrated in cancer patients who undergo hematopoietic stem cell transplantation (Jeon et al, 2015). …”

Section: Discussionmentioning

confidence: 99%

Coping Strategies in Liver Transplant Recipients and Caregivers According to Patient Posttraumatic Growth

et al. 2017

View full text Add to dashboard Cite

The purpose of this study was to analyze the differences in coping strategies employed by liver transplant recipients and their family members according to patient posttraumatic growth. Two matched groups of 214 liver transplant recipients and 214 family members were selected. The Posttraumatic Growth Inventory and Brief COPE were used. The most relevant results were: (1) Interactive effects in active coping, support (instrumental and emotional) and acceptance strategies, which were all used more by patients with higher growth levels, while their family members showed no differences in use of these strategies by patient growth level. Furthermore, while a low level of patient growth did not mark differences between them and their caregivers, a high level did, patients employing more active coping and support (instrumental and emotional), (2) In both groups a high level of patient growth was associated with more use of positive reframing and denial than a low one, and (3) Self-blame was employed by patients more than by their caregivers. It was concluded that a high level of posttraumatic growth in liver transplant recipients is associated with more use of healthy coping strategies, basically active coping, instrumental support, and emotional support.

show abstract

“…Some studies have used generic measures, such as the 36-Item Short Form Health Survey [ 7 ] to evaluate the QOL of lymphoma survivors [ 8 ] as well; however, it also has limitations because it does not address specific problems experienced by cancer survivors [ 3 ]. Moreover, although studies have reported that survivors also experience positive changes associated with having cancer, such as post-traumatic growth and appreciation of life [ 9 ], most instruments do not assess the positive effects of experience with cancer.…”

Section: Introductionmentioning

confidence: 99%

Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors

et al. 2018

View full text Add to dashboard Cite

PurposeThe objective of this study was to validate the Korean version of the Quality of Life–Cancer Survivors (QOL-CS-K) in a sample of lymphoma survivors.Materials and MethodsWe conducted a cross-sectional survey of lymphoma survivors who had survived for at least 24 months since diagnosis. Participants were recruited at the outpatient clinics and at a hospital event in a tertiary hospital in Seoul, Korea. Survivors were asked to complete the QOL-CS-K and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) questionnaires. To determine test-retest reliability, a second questionnaire was sent to participants who completed the first questionnaire adequately. Exploratory factor analysis and Pearson’s correlations were used for evaluating reliability and validity of the QOL-CS-K.ResultsAmong 257 survivors, 245 (95.3%) completed all questionnaires and had no missing data. The mean age of study participants was 52.2 years, 54.9% were men, and the mean time since diagnosis was 4.0±1.6 years. The Cronbach’s α for the overall QOL-CS-K was 0.90, and the α coefficients for each subscale ranged from 0.73 to 0.83. The test and retest reliability was 0.88. Moderate correlations were found between comparable subscales of the QOL-CS-K and subscales of the EORTC QLQ-C30 (r=0.51-0.55) except for the spiritual well-being subscale of the QOL-CS-K, which did not correlate with any of the EORTC QLQ-C30 subscales (–0.08 to 0.16).ConclusionThe QOL-CS-K is a reliable and valid scale for measuring the QOL in long-term lymphoma survivors.

show abstract

Post‐traumatic growth in survivors of allogeneic hematopoietic stem cell transplantation

Abstract: We suggest implementing programs for HSCT patients to enhance support from healthcare professionals and to increase post-traumatic growth through greater utilization of nurse counseling, self-help meetings, and writing.

Cited by 23 publications

References 30 publications

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report

Coping Strategies in Liver Transplant Recipients and Caregivers According to Patient Posttraumatic Growth

Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors

Contact Info

Product

Resources

About